161 related articles for article (PubMed ID: 6391658)
1. A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation.
Ohno R; Yamada K; Masaoka T; Ohshima T; Amaki I; Hirota Y; Horikoshi N; Horiuchi A; Imai K; Kimura I
Cancer Immunol Immunother; 1984; 18(3):149-54. PubMed ID: 6391658
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled study of chemoimmunotherapy of acute myelogenous leukemia (AML) in adults with Nocardia rubra cell-wall skeleton and irradiated allogeneic AML cells.
Ohno R; Nakamura H; Kodera Y; Ezaki K; Yokomaku S; Oguma S; Kubota Y; Shibata H; Ogawa N; Masaoka T
Cancer; 1986 Apr; 57(8):1483-8. PubMed ID: 3512070
[TBL] [Abstract][Full Text] [Related]
3. Maintenance chemoimmunotherapy of nonlymphoblastic acute leukemias.
Favre R; Sebahoun G; Bagarry-Liégey D; Imbert C; Ciardelli P; Gastaut JA; Meyer G; Carcassonne Y
Recent Results Cancer Res; 1982; 80():56-63. PubMed ID: 7036297
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults.
Ota K; Ogawa N
Biomed Pharmacother; 1990; 44(2):93-101. PubMed ID: 2224060
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy of acute myelogenous leukemia (AML) in adults with the Nocardia rubra cell wall skeleton].
Ohno R; Nakamura H; Kodera Y; Masaoka T; Yamada K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1264-9. PubMed ID: 3524463
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial.
Vogler WR; Winton EF; Gordon DS; Raney MR; Go B; Meyer L
Blood; 1984 May; 63(5):1039-45. PubMed ID: 6201211
[TBL] [Abstract][Full Text] [Related]
8. Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up.
Dutcher JP; Wiernik PH; Markus S; Weinberg V; Schiffer CA; Harwood KV
Leukemia; 1988 Jul; 2(7):413-9. PubMed ID: 3393023
[TBL] [Abstract][Full Text] [Related]
9. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
Presant CA; Berger NA; Klahr C; Phillips GL
Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
[TBL] [Abstract][Full Text] [Related]
10. [Alternatives and further development of therapy of acute myeloid leukemia in adults. Update of West German multicenter studies].
Büchner T; Urbanitz D; Hiddemann W; Koch P; Pielken HJ; Kuse R; Mohr A; Maschmeyer G; Kreutzmann H; Wendt F
Onkologie; 1987 Feb; 10(1):14-6. PubMed ID: 3295620
[TBL] [Abstract][Full Text] [Related]
11. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with allogeneic neuraminidase-treated blasts for maintenance in acute myelogenous leukemia (AML). Significant prolongation of remission duration in patients receiving at least 3 cycles of therapy.
Urbanitz D; Pielken HJ; Koch P; Büchner T; Hiddemann W; Heinecke A; Wendt F; Maschmeier G; van de Loo J
Onkologie; 1985 Jun; 8(3):157-9. PubMed ID: 3895098
[TBL] [Abstract][Full Text] [Related]
13. Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.
Cassileth PA; Harrington DP; Hines JD; Oken MM; Mazza JJ; McGlave P; Bennett JM; O'Connell MJ
J Clin Oncol; 1988 Apr; 6(4):583-7. PubMed ID: 3282032
[TBL] [Abstract][Full Text] [Related]
14. A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA.
Mandelli F; Vegna ML; Avvisati G; Amadori S; Spadea A; Cacciola E; Cantore N; De Laurenzi A; De Rosa C; Fioritoni G
Ann Hematol; 1992 Apr; 64(4):166-72. PubMed ID: 1581404
[TBL] [Abstract][Full Text] [Related]
15. Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemia.
Takahashi I; Yorimitsu S; Hara M; Inagaki T; Nakada H; Sekito N; Hayashi N; Nonaka K; Ohmoto E; Uchida K
Acta Med Okayama; 1986 Jun; 40(3):175-7. PubMed ID: 3461685
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan.
Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
Am J Clin Oncol; 1995 Jun; 18(3):216-22. PubMed ID: 7747709
[TBL] [Abstract][Full Text] [Related]
17. Chemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia.
Eppinger-Helft M; Pavlovsky S; Hidalgo G; Muriel FS; Suárez A; Garay G; Russo C; Santos M; Macchi A; Lein J
Cancer; 1980 Jan; 45(2):280-4. PubMed ID: 6985835
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: a report from Children's Cancer Study Group.
Movassaghi N; Higgins G; Pyesmany A; Baehner R; Chard R; Sather H; Hammond D
Med Pediatr Oncol; 1984; 12(5):352-6. PubMed ID: 6208468
[TBL] [Abstract][Full Text] [Related]
19. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313
[TBL] [Abstract][Full Text] [Related]
20. Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan.
Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
Cancer Invest; 1995; 13(4):363-9. PubMed ID: 7627722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
